NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Spherix Incorporated


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


 Refine Search
Display Mode: Context | Summary
Spherix Announces Full-Scale Production of Pharmaceutical Tagatose
2009 JUL 6 ... Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a provider of ...
Subject: Diabetes
Price: $3.00
*
Spherix Announces Positive Phase 2 Study Results
2009 JUL 6 ... Spherix Incorporated (Nasdaq CM: SPEX), an innovator in biotechnology for diabetes therapy, and a provider of ...
Subject: Diabetes
Price: $3.00
*
Spherix Incorporated Appoints Dr. Ram Nimmagudda As Director of New Business Development
2009 SEP 21 ... Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a provider of ...
Subject: Biotech Business
Price: $3.00
*
Spherix Incorporated Selects LaVoie Group As Corporate Communications/Public Relations Agency
2009 OCT 26 ... science-focused strategic communications agency, announced that it has been selected by Spherix Incorporated (NASDAQ:SPEX) to represent them for corporate communications and public relations. ...
Subject: LaVoie Group
Price: $3.00
*
Spherix Incorporated to Present at the Rodman & Renshaw 11th Annual Healthcare Conference
2009 SEP 14 ... Keywords: Biotechnology, Diabetes, Pharmaceuticals, Therapy, Treatment, Spherix Incorporated. This article was prepared by Biotech Business Week editors from staff and ...
Subject: Biotechnology
Price: $3.00
*
Spherix Postpones 2009 Annual Shareholders Meeting to Share Interim Diabetes Clinical Trial Data
2009 MAR 23 ... Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology and a provider of technical and regulatory ...
Subject: Diabetes
Price: $3.00
*
Spherix Recruiting New 'Independent' Director to Regain NASDAQ Compliance
2009 MAY 11 ... Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a provider of ...
Subject: Biotechnology
Price: $3.00
*
Spherix Reports First Quarter 2009 Earnings
2009 JUN 1 ... Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a provider of ...
Subject: Biotechnology
Price: $3.00
*
Spherix Reports Second Quarter 2009 Earnings
2009 AUG 31 ... Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a provider of ...
Subject: Biotechnology
Price: $3.00
*
Spherix to Exhibit at the BIO 2009 International Convention
2009 MAY 25 ... Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a provider of ...
Subject: Biotechnology
Price: $3.00
*
Patient Recruitment Begins in India for Phase 3 Diabetes Trial
2008 NOV 24 ... Spherix Incorporated (NASDAQ:SPEX) reported that patient recruitment for its Phase 3 clinical trial of its ...
Subject: Diabetes
Price: $3.00
*
Spherix Expands Phase 3 Naturlose Diabetes Trial Outside of the U.S.
2008 JUL 28 ... Spherix Incorporated (NASDAQ:SPEX) reported that the Phase 3 clinical trial of its potential type 2 diabetes ...
Subject: Obesity and Diabetes
Price: $3.00
*
Spherix Incorporated to Seek Stockholder Approval of Reverse Stock Split
2008 SEP 23 ... Spherix Incorporated (NASDAQ:SPEX) announced that it will seek stockholder approval to implement a reverse ...
Subject: Spherix Incorporated
Price: $3.00
*
Spherix Receives NASDAQ Bid Price Deficiency Letter
2008 AUG 4 ... Spherix Incorporated (NASDAQ:SPEX) reported that on July 21, 2008, it received written notification from ...
Subject: Biotech Business
Price: $3.00
*
Spherix Receives Nasdaq Letter Extending Minimum Bid Price Compliance Period
2008 NOV 3 ... Spherix Incorporated (NASDAQ:SPEX) reported that on October 22, 2008, it received written notification from ...
Subject: Biotech Business
Price: $3.00
*
Spherix Reports 2nd Quarter Earnings
2008 AUG 25 ... Spherix Incorporated (NASDAQ:SPEX) reported a net loss for the three and six months ended June 30, 2008 of ...
Subject: Spherix Incorporated
Price: $3.00
*
Spherix Stockholders Authorize Potential Reverse Stock Split
2008 DEC 2 ... Spherix Incorporated (NASDAQ:SPEX) reported that at a special meeting of stockholders held on November 17, ...
Subject: Spherix Incorporated
Price: $3.00
*
Spherix Transfers Stock Listing to Nasdaq Capital Market
2008 NOV 25 ... Spherix Incorporated (NASDAQ:SPEX) reported that the Nasdaq Stock Market has approved its application to ...
Subject: Spherix Incorporated
Price: $3.00
*

Results 1 - 20      Next >

-----------------------
Home | Free Newsletters | Products | Article Library | About Us | Contact | Privacy Policy | Search | Visit VerticalNews.com
Copyright © 2009 NewsRx		 PR Login